- HEXO’s stock has rallied by nearly 175 per cent since the pandemic-led meltdown on March 19.
- HEXO’s 10-day average stock trading volume is 4.27 million units.
- Aphria stocks have zoomed over 260 per cent since the pandemic-led market collapse on March 17.
- In its YTD performance, stocks of Aphria have soared nearly 77 per cent.
Pot stocks Aphria (TSX: APHA) and HEXO Corp (TSX: HEXO) were among the most active cannabis stocks in the Canadian markets on Monday. Leading Canadian cannabis producer Aphria concluded its purchase of SweetWater, a US-based brewing company, on November 30. As part of this agreement, unitholders of SweetWater secured US$ 250 million in cash and US$ 50 million in Aphria shares.
HEXO, on the other hand, confirmed in its exchange filing that it will join the Cowen 2020 Boston Cannabis Conference on December 2, 2020. The company CEO Sebastien St. Louis will be one of the panelists on Beverages, Beer, and Beyond.
With both the pot firms trying to leverage on Democrats’ promised legalization of recreational cannabis, let us have a quick look at their stock performances:
Current Stock Price: C$ 1.43
Quebec-based HEXO Corp manufactures and supplies consumer packaged cannabis items to serve the worldwide cannabis market.
HEXO Stock Performance
This pot stock has rallied by nearly 175 per cent since the pandemic-led meltdown on March 19. The cannabis share has surged over 52 per cent in the last six months. However, HEXO stocks have declined by 28.5 per cent in its year-to-date performance.
Its 10-day average stock trading volume is 4.27 million units. The stock made it among TMX’s Top actively traded stocks in the last 10 days. Its current market capitalization is approximately C$ 691 million. Its debt to equity ratio is0.21 and its price-to-book (P/B) ratio is 1.254.
In the fourth quarter of fiscal 2020, HEXO posted net revenue of C$ 27.1 million, a rise of 76 per cent from Q4 FY19. The cannabis company reported a gross profit of C$ 26.953 million in Q4 FY20, a 26.27 per cent surge compared to C$ 21.344 million in the same period the prior year.
Aphria (TSX: APHA)
Current Market Stock: C$ 10.91
Ontario-based Aphria Inc. is a leading global cannabis company that has been producing low-cost cannabis at scale organically. The pot company is expected to expand its global cannabis market.
Aphria management said that they are looking to grow their market and capitalize on SweetWater’s resources to accelerate its entry to the American market on the back of the US president-elect Joe Biden’s push for legalization of cannabis.
Aphria Stock Performance
The cannabis stock is trading up 82.44 per cent in the last six months. The pot stock has zoomed over 260 per cent since the pandemic-led market collapse on March 17. In its year-to-date performance, stocks of Aphria have soared nearly 77 per cent.
The pot company’s 10-day average trading volume is 5.95 million units. The cannabis producer has been ranked among TMX’s most actively traded stocks across the TSX and TSXV in the last 10 days. The company has also been placed to TMX’s top healthcare stocks that have surpassed the TSX and TSX venture with the largest price gain in the last 30 days.
The midcap pot company's current market cap is approximately C$ 3.257 billion. Its price-to-book ratio is 1.746, and the current debt-to-equity (D/B) ratio stands at 0.23. the price-to-cashflow (P/CF) ratio is 2681.60, according to the TMX website.
Aphria’s net cannabis revenue surged 103 per cent in the first quarter of fiscal 2021 from the prior-year quarter.
The company registered net revenue of C$ 145.7 million in Q1 FY21, with 16 per cent year-over-year growth. The company reported the sixth successive quarter of revenue gains.